GlassScriptPhysician profile
Katelyn Ann Puryear
NPI 1912516394
$21,613.66
in general payments reported to CMS, 2019-2025
43 companies · $5,682 in 2025
The $5,682 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,637 · 2022: $3,662 · 2023: $6,232 · 2024: $4,401 · 2025: $5,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $1,282 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,854.07 |
| Travel and Lodging | $1,281.63 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,886.74 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Inspire Medical Systems, INC. | $2,415.44 | 2021-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,067.47 | 2021-2025 | Ofev, Jardiance, Jascayd |
| Genzyme Corporation | $1,540.99 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,454.69 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Insmed, INC. | $1,314.07 | 2021-2025 | Arikayce, Brinsupri |
| Amgen INC. | $903.44 | 2021-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $884.45 | 2022-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $811.60 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Jazz Pharmaceuticals INC. | $629.00 | 2021-2025 | |
| Harmony Biosciences LLC | $565.52 | 2022-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $482.10 | 2021-2025 | Glassia |
| Merck Sharp & Dohme LLC | $478.94 | 2021-2025 | Winrevair, Zerbaxa, Belsomra |
| Baxter Healthcare | $458.02 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Inogen, INC. | $414.47 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $373.87 | 2022-2025 | Sunosi |
| Verona Pharma, INC. | $336.97 | 2025 | Ohtuvayre |
| Electromed, INC. | $328.97 | 2022-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $316.70 | 2022-2024 | |
| Gilead Sciences, INC. | $298.40 | 2021-2023 | Veklury |
| Mallinckrodt Hospital Products INC. | $291.10 | 2021-2025 | Acthar, Terlivaz |
| Fisher & Paykel Healthcare INC | $257.62 | 2022-2025 | Fisher & Paykel Healthcare |
| Pulmonx Corporation | $250.06 | 2024-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Mylan Specialty L.P. | $222.33 | 2022-2024 | Yupelri |
| Sanofi-Aventis U.S. LLC | $199.33 | 2023-2025 | |
| Genentech USA, INC. | $177.98 | 2022-2024 | Xolair |
| Viatris Specialty LLC | $174.15 | 2025 | Yupelri |
| United Therapeutics Corporation | $144.11 | 2024-2025 | Tyvaso, Tyvaso |
| Abbvie INC. | $140.31 | 2023-2025 | |
| Ani Pharmaceuticals, INC. | $138.32 | 2022-2024 | Purified Cortrophin Gel |
| Avadel Cns Pharmaceuticals, LLC | $126.36 | 2024-2025 | Lumryz |
| Alexion Pharmaceuticals, INC. | $96.46 | 2021-2025 | Ultomiris |
| Lilly USA, LLC | $88.48 | 2025 | Zepbound, Mounjaro |
| Philips North America LLC | $80.40 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Shionogi INC | $76.97 | 2023-2025 | Fetroja |
| Paratek Pharmaceuticals, INC. | $45.59 | 2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $33.40 | 2022 | |
| Masimo Corporation | $29.09 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $28.47 | 2022-2023 | Eliquis |
| Vyera Pharmaceuticals, LLC | $19.06 | 2021 | |
| Kyowa Kirin, INC. | $15.24 | 2021 | |
| Phadia US INC. | $14.29 | 2024 | Immunocap |
| 3b Medical, INC. | $2.69 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Puryear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.